GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Operating Margin %

PARNF (Parnell Pharmaceuticals Holdings) Operating Margin % : 12.88% (As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Parnell Pharmaceuticals Holdings's Operating Income for the six months ended in Dec. 2018 was $2.45 Mil. Parnell Pharmaceuticals Holdings's Revenue for the six months ended in Dec. 2018 was $19.03 Mil. Therefore, Parnell Pharmaceuticals Holdings's Operating Margin % for the quarter that ended in Dec. 2018 was 12.88%.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's Operating Margin % or its related term are showing as below:


PARNF's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.57
* Ranked among companies with meaningful Operating Margin % only.

Parnell Pharmaceuticals Holdings's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Parnell Pharmaceuticals Holdings's Operating Income for the six months ended in Dec. 2018 was $2.45 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2018 was $2.45 Mil.


Parnell Pharmaceuticals Holdings Operating Margin % Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Operating Margin % Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Operating Margin %
Get a 7-Day Free Trial -58.29 -62.58 -93.33 -54.32 12.88

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Operating Margin % Get a 7-Day Free Trial -58.29 -62.58 -93.33 -54.32 12.88

Competitive Comparison of Parnell Pharmaceuticals Holdings's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnell Pharmaceuticals Holdings's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Operating Margin % falls into.



Parnell Pharmaceuticals Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Parnell Pharmaceuticals Holdings's Operating Margin % for the fiscal year that ended in Dec. 2018 is calculated as

Operating Margin %=Operating Income (A: Dec. 2018 ) / Revenue (A: Dec. 2018 )
=2.451 / 19.031
=12.88 %

Parnell Pharmaceuticals Holdings's Operating Margin % for the quarter that ended in Dec. 2018 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2018 ) / Revenue (Q: Dec. 2018 )
=2.451 / 19.031
=12.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnell Pharmaceuticals Holdings  (OTCPK:PARNF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Parnell Pharmaceuticals Holdings Operating Margin % Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnell Pharmaceuticals Holdings Business Description

Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.